| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.57 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |